Class · Senolytics · Emerging Longevity

Senolytics: Clearing Zombie Cells

Senolytics selectively kill senescent cells: the damaged cells that refuse to die, secrete inflammatory signals, and drive age-related decline. D+Q is the flagship; fisetin is the OTC cousin.

🔬 Senolytics are HighPeptides' bet on the clearest mechanistic pathway from lab longevity to clinical longevity. If it works in humans, it's the first real rejuvenation drug class.
2 days
Hit-and-Run Cycle
30 days
Between Cycles
10%
Mouse Lifespan Extension

Build your own printable peptide tracker

A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.

Stacking compounds? Check interactions first →

Build your tracker →

How It Works

🧟
Zombie Cell Clearance

Senescent cells accumulate with age. They refuse to divide but also refuse to die, secreting SASP cytokines that inflame surrounding tissue. Senolytics selectively trigger their apoptosis.

⚔️
BCL-2 Pathway Disruption

Dasatinib and quercetin disrupt the survival-protein signaling that senescent cells depend on. Healthy cells have alternate pathways; senescent cells don't.

🧠
Tissue-Wide Effects

In mice, D+Q cleared senescent cells across multiple organs: adipose, liver, kidney, lung, and brain. Functional outcomes improved in each.

🔬
Human Trials Underway

Small Phase 2 studies at Mayo Clinic and Baptist Health showing senescent-cell reduction in human fat tissue. Efficacy endpoints (frailty, IPF) still being collected.

What the Data Shows

Mouse healthspan extension (D+Q)
Mayo Clinic 2018
+36%
Mouse lifespan extension (naturally aged)
D+Q intermittent dosing
+10%
Adipose senescent-cell reduction (humans)
Open-label pilot
~30%
Definitive human efficacy RCT
Not yet reported
Pending

Key Takeaways

What We Know
  • Senescent cell accumulation is a validated aging mechanism ("hallmark of aging")
  • D+Q reduces senescent cells in human adipose tissue (Mayo open-label data)
  • Mouse studies show healthspan + lifespan extension with intermittent dosing
  • Hit-and-run protocol is plausible: you don't need chronic exposure
  • Fisetin offers an OTC alternative with some of the same mechanism at lower potency
What We Don't Know
  • Human efficacy for disease endpoints (frailty, fibrosis, cognition) is unproven
  • Dasatinib is a leukemia drug with known side effects (bleeding, edema, pleural effusion)
  • Optimal human dosing and cycling frequency not established
  • Senolytics may not clear ALL senescent cell subtypes
  • Rebound senescence: cells may re-accumulate between cycles

Frequently Asked Questions

What is the D+Q protocol?

Most protocols use dasatinib 100mg + quercetin 1000mg orally for 2 consecutive days, once per month. This matches the Mayo Clinic Phase 2 dosing and allows time for senescent cells to clear without chronic exposure to the drugs.

Can I do senolytics without a prescription?

Yes, fisetin alone is OTC and has senolytic activity at 20mg/kg doses. D+Q requires a prescription for dasatinib. Some anti-aging clinics prescribe D+Q specifically for senolytic use.

How often should I cycle senolytics?

Most protocols cycle monthly. Some clinicians recommend every 3-6 months. There is no established optimal interval in humans.

What are the side effects?

Dasatinib: bleeding risk, fluid retention, pleural effusion, fatigue. Quercetin and fisetin are generally well-tolerated at senolytic doses. Intermittent dosing reduces cumulative risk.

Recommended Products

Support supplements and gear relevant to this protocol.

Affiliate links support HighPeptides at no extra cost.

Ebook
The Complete Peptide Protocol Guide

67-page guide: protocols, dosing, sourcing. Everything in one place.

Get the guide: $19 (normally $29) → The Peptide Buyer’s Playbook ($19) The Peptide Buyer’s Playbook ($19) All ebooks & guides →
Disclaimer

Dasatinib is a prescription oncology drug. Quercetin and fisetin are dietary supplements. The senolytic protocols described are investigational.

Not medical advice. Consult a qualified healthcare provider before starting senolytic therapy — especially if you take anticoagulants or have cardiovascular disease.

📘

Get the Free 2026 Peptide Protocol Stack

Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.